The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome

International Journal of Cancer

Volumn 129, Issue 3, 2011, Pages 565-573

  Chan, Stephen Ho Kin ^a   Yee Ko, Josephine Mun ^b   Chan, Kwok Wah ^b   Chan, Yuen Piu ^b   Tao, Qian ^c   Hyytiainen, Marko ^d   Keski Oja, Jorma ^d   Law, Simon ^b   Srivastava, Gopesh ^b   Tang, Johnny ^e   Tsao, Sai Wah ^b   Chen, Han ^a   Stanbridge, Eric J ^f   Lung, Maria Li ^b  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antiangiogenesis; ESCC; extracellular matrix protein; hypermethylation; invasion; LOH; LTBP 2; microcell mediated chromosome transfer; migration; tumor suppressor gene

Indexed keywords

LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 2; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENDOTHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LTBP 2 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LATENT TGF-BETA BINDING PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; TUMOR STEM CELL ASSAY;

EID: 79958026767     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25698     Document Type: Article

References (47)

1. Stoner GD, Gupta A,. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22: 1737-46. (Pubitemid 33064837)
2. Pack SD, Karkera JD, Zhuang Z, Pak ED, Balan KV, Hwu P, Park WS, Pham T, Ault DO, Glaser M, Liotta L, Detera-Wadleigh SD, et al. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 1999; 25: 160-8. (Pubitemid 29226599)
3. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM, Jr, Menon AG,. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 1995; 55: 4696-701.
4. Pehlivan D, Gunduz E, Gunduz M, Nagatsuka H, Beder LB, Cengiz B, Rivera RS, Fukushima K, Palanduz S, Ozturk S, Yamanaka N, Shimizu K,. Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol 2008; 134: 1267-76.
5. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P, Kovacs G,. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 1997; 19: 29-35. (Pubitemid 27193717)
6. Piao Z, Park C, Park JH, Kim H,. Allelotype analysis of hepatocellular carcinoma. Int J Cancer 1998; 75: 29-33. (Pubitemid 28113973)
7. Bando T, Kato Y, Ihara Y, Yamagishi F, Tsukada K, Isobe M,. Loss of heterozygosity of 14q32 in colorectal carcinoma. Cancer Genet Cytogenet 1999; 111: 161-5. (Pubitemid 29232868)
8. Ko JM, Yau WL, Chan PL, Lung HL, Yang L, Lo PH, Tang JC, Srivastava G, Stanbridge EJ, Lung ML,. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 2005; 43: 284-93. (Pubitemid 40726873)
9. Tang JC, Wan TS, Wong N, Pang E, Lam KY, Law SY, Chow LM, Ma ES, Chan LC, Wong J, Srivastava G,. Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genet Cytogenet 2001; 124: 36-41. (Pubitemid 32101470)
10. Hu CP, Hsieh HG, Chien KY, Wang PY, Wang CI, Chen CY, Lo SJ, Wuu KD, Chang CM,. Biologic properties of three newly established human esophageal carcinoma cell lines. J Natl Cancer Inst 1984; 72: 577-83.
11. Takahashi K, Kanazawa H, Chan H, Hosono T, Takahara M, Sato K,. A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T.T. and T.Tn.). Jpn J Oral Maxillofac Surg 1990; 36: 307-16.
12. Hu YC, Lam KY, Law SY, Wan TS, Ma ES, Kwong YL, Chan LC, Wong J, Srivastava G,. Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 2002; 135: 120-7. (Pubitemid 34786763)
13. Mok CH, Chew EC, Riches DJ, Lee JC, Huang DP, Hadgis C, Crofts TJ,. Biological characteristics of a newly established human oesophageal carcinoma cell line. Anticancer Res 1987; 7: 409-15. (Pubitemid 17151921)
14. Pan QQ,. Studies on esophageal cancer cells in vitro. Proc Chin Acad Med Sci Peking Union Med Coll 1989; 4: 52-7.
15. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T,. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992; 69: 277-84.
16. Lo PH, Leung AC, Kwok CY, Cheung WS, Ko JM, Yang LC, Law S, Wang LD, Li J, Stanbridge EJ, Srivastava G, Tang JC, et al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 2007; 26: 148-57. (Pubitemid 46067340)
17. Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW, Kwong YL,. Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet 2006; 165: 25-35. (Pubitemid 43254649)
18. Leung AC, Wong VC, Yang LC, Chan PL, Daigo Y, Nakamura Y, Qi RZ, Miller LD, Liu ET, Wang LD, Li JL, Law S, et al. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int J Cancer 2008; 122: 587-94. (Pubitemid 350308950)
19. Hyytiainen M, Taipale J, Heldin CH, Keski-Oja J,. Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem 1998; 273: 20669-76. (Pubitemid 28377639)
20. Lo PH, Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML,. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett 2006; 234: 184-92.
21. Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L, et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 2005; 24: 6525-32. (Pubitemid 41486635)
22. Leung AC, Wong VC, Yang LC, Chan PL, Daigo Y, Nakamura Y, Qi RZ, Miller LD, Liu ET, Wang LD, Li JL, Law S, et al. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int J Cancer 2008; 122: 587-94. (Pubitemid 350308950)
23. Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res 2008; 6: 592-603. (Pubitemid 351521841)
24. Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC, Wang X, Chan KW,. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer 2007; 97: 1409-15. (Pubitemid 350114787)
25. Ali M, McKibbin M, Booth A, Parry DA, Jain P, Riazuddin SA, Hejtmancik JF, Khan SN, Firasat S, Shires M, Gilmour DF, Towns K, et al. Null mutations in LTBP2 cause primary congenital glaucoma. Am J Hum Genet 2009; 84: 664-71.
26. Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA, Lauwerys BR,. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1579-88. (Pubitemid 46764087)
27. Riegman PH, Vissers KJ, Alers JC, Geelen E, Hop WC, Tilanus HW, van Dekken H,. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res 2001; 61: 3164-70. (Pubitemid 32691970)
28. Hunter KW,. Host genetics and tumour metastasis. Br J Cancer 2004; 90: 752-5. (Pubitemid 38406581)
29. Carragher NO, Frame MC,. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol 2004; 14: 241-9. (Pubitemid 38591328)
30. Hyytiainen M, Keski-Oja J,. Latent TGF-beta binding protein LTBP-2 decreases fibroblast adhesion to fibronectin. J Cell Biol 2003; 163: 1363-74. (Pubitemid 38032096)
31. Wall SJ, Jiang Y, Muschel RJ, DeClerck YA,. Meeting report: proteases, extracellular matrix, and cancer: an AACR Special Conference in Cancer Research. Cancer Res 2003; 63: 4750-5. (Pubitemid 36951057)
32. Kerbel RS,. Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000; 21: 505-15. (Pubitemid 30137936)
33. Bingle L, Brown NJ, Lewis CE,. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196: 254-65. (Pubitemid 34189413)
34. Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW,. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 2001; 93: 781-5. (Pubitemid 32756746)
35. Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A,. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 2001; 7: 285-9. (Pubitemid 32183031)
36. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M,. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001; 159: 893-903. (Pubitemid 32847180)
37. O'Sullivan C, Lewis CE, Harris AL, McGee JO,. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 1993; 342: 148-9. (Pubitemid 23200443)
38. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C,. Macrophages and angiogenesis. J Leukoc Biol 1994; 55: 410-22. (Pubitemid 24097250)
39. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC,. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005; 23: 953-64. (Pubitemid 46202315)
40. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ,. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 2002; 94: 1134-42. (Pubitemid 34919050)
41. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD,. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-9. (Pubitemid 27010100)
42. Eklund L, Olsen BR,. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006; 312: 630-41. (Pubitemid 43290339)
43. Derynck R, Akhurst RJ, Balmain A,. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-29. (Pubitemid 32952643)
44. Fukuchi M, Miyazaki T, Fukai Y, Nakajima M, Sohda M, Masuda N, Manda R, Tsukada K, Kato H, Kuwano H,. Plasma level of transforming growth factor beta1 measured from the azygos vein predicts prognosis in patients with esophageal cancer. Clin Cancer Res 2004; 10: 2738-41. (Pubitemid 38509149)
45. Hirani R, Hanssen E, Gibson MA,. LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. Matrix Biol 2007; 26: 213-23. (Pubitemid 46660588)
46. Mantovani A,. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 1994; 71: 5-16. (Pubitemid 24246016)
47. Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S,. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 2004; 99: 1667-74. (Pubitemid 39237489)